| Target Price | $494.70 |
| Price | $401.65 |
| Potential | 23.17% |
| Number of Estimates | 33 |
| 33 Analysts have issued a price target Intuitive Surgical 2027 . The average Intuitive Surgical target price is $494.70. This is 23.17% higher than the current stock price. The highest price target is $719.25 79.07% , the lowest is $327.24 18.53% . | |
| A rating was issued by 40 analysts: 29 Analysts recommend Intuitive Surgical to buy, 10 to hold and 1 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Intuitive Surgical stock has an average upside potential 2027 of 23.17% . Most analysts recommend the Intuitive Surgical stock at Purchase. |
36 Analysts have issued a sales forecast Intuitive Surgical 2026 . The average Intuitive Surgical sales estimate is
This results in the following potential growth metrics:
27 Analysts have issued an Intuitive Surgical EBITDA forecast 2026. The average Intuitive Surgical EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
37 Intuitive Surgical Analysts have issued a net profit forecast 2026. The average Intuitive Surgical net profit estimate is
This results in the following potential growth metrics and future Net Margins:
37 Analysts have issued a Intuitive Surgical forecast for earnings per share. The average Intuitive Surgical EPS is
This results in the following potential growth metrics and future valuations:
Intuitive Surgical...
| Analyst | Rating | Action | Date |
|---|---|---|---|
| BTIG |
Buy
➜
Buy
|
Unchanged | Sep 08 2026 |
| Oppenheimer |
Perform
➜
Outperform
|
Upgrade | Aug 12 2026 |
| HSBC |
Buy
➜
Hold
|
Downgrade | Jul 30 2026 |
| Evercore ISI Group |
In-Line
➜
In-Line
|
Unchanged | Jul 17 2026 |
| Wells Fargo |
Overweight
➜
Overweight
|
Unchanged | Jul 17 2026 |
| Baird |
Outperform
➜
Outperform
|
Unchanged | Jul 17 2026 |
| BTIG |
Buy
➜
Buy
|
Unchanged | Jul 17 2026 |
| Analyst Rating | Date |
|---|---|
|
Unchanged
BTIG:
Buy
➜
Buy
|
Sep 08 2026 |
|
Upgrade
Oppenheimer:
Perform
➜
Outperform
|
Aug 12 2026 |
|
Downgrade
HSBC:
Buy
➜
Hold
|
Jul 30 2026 |
|
Unchanged
Evercore ISI Group:
In-Line
➜
In-Line
|
Jul 17 2026 |
|
Unchanged
Wells Fargo:
Overweight
➜
Overweight
|
Jul 17 2026 |
|
Unchanged
Baird:
Outperform
➜
Outperform
|
Jul 17 2026 |
|
Unchanged
BTIG:
Buy
➜
Buy
|
Jul 17 2026 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


